Inspire Medical Systems Quarterly Cash Flow Statement
NYSE: INSPHealth CareMedical/Dental InstrumentsUSD
68.89+2.20 (+3.30%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Inspire Medical Systems free cash flow
In the quarter ended Jun 30, 2026, Inspire Medical Systems generated $23.2 million of operating cash flow and spent $9.2 million on capital expenditures. That left free cash flow of $14.1 million, a free-cash-flow margin of 7.0% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Inspire Medical Systems cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 314.00K | -11.29M | 136.09M | 9.93M | -3.59M | 2.99M | 35.22M | 18.50M | 9.79M | -10.01M | 14.76M | -8.54M |
| Net Income growth (YoY) | — | -477.47% | +286.36% | -46.30% | -136.68% | — | +138.60% | — | — | — | +368.67% | — |
| Depreciation & Amortization | 4.60M | 5.11M | 3.82M | 3.68M | 3.41M | 3.04M | 2.48M | 1.85M | 1.38M | 839.00K | 817.00K | 777.00K |
| Stock-Based Compensation | 31.20M | 30.69M | 28.01M | 29.50M | 41.70M | 31.06M | 29.14M | 28.20M | 32.30M | 26.32M | 22.85M | 19.83M |
| Change in Working Capital | -18.93M | -787.00K | -33.48M | 14.64M | -47.56M | -27.09M | -10.55M | 5.68M | -41.54M | -4.95M | -29.99M | -9.30M |
| Operating Cash Flow | 23.23M | 12.85M | 52.47M | 68.53M | 2.68M | -6.70M | 69.18M | 52.28M | -78.00K | 8.86M | 17.27M | 3.64M |
| Capital Expenditures | -9.16M | -9.73M | -10.66M | -10.44M | -9.00M | -8.41M | -7.03M | -8.01M | -12.39M | -11.70M | -8.03M | -6.99M |
| Investing Cash Flow | 3.55M | -11.25M | -11.92M | -11.64M | 46.56M | -1.55M | 3.76M | -102.97M | 5.62M | -19.54M | -151.72M | -144.24M |
| Share Repurchases | 0 | 0 | -50.01M | -50.00M | 0 | -75.01M | 0 | 0 | 0 | 0 | — | — |
| Debt Repaid | — | — | — | — | — | — | — | — | — | — | 0 | 0 |
| Financing Cash Flow | 1.91M | -7.48M | -48.31M | -51.08M | 3.70M | -87.76M | -70.14M | 9.89M | 7.09M | 768.00K | -10.12M | 3.50M |
| Net Change in Cash | 28.83M | -5.88M | -8.03M | 5.92M | 53.05M | -96.27M | 2.64M | -40.52M | 12.62M | -10.12M | -144.36M | -137.15M |
| Free Cash Flow | 14.07M | 3.12M | 41.81M | 58.09M | -6.31M | -15.11M | 62.15M | 44.28M | -12.47M | -2.84M | 9.23M | -3.35M |
This table shows 12 quarterly periods of Inspire Medical Systems's cash flow statement, from Q2 2026 back to Q3 2023, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow INSP's reporting calendar. What is a cash flow statement?